About 16 results found for searched term "Cholic acid sodium" (0.052 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M11152 | Deoxycholic acid sodium salt | GPCR19/TGR5 |
| Sodium deoxycholate | ||
| Deoxycholic acid sodium salt is a bile acid and a by-product of intestinal metabolism, Deoxycholic acid sodium salt can activate the G protein-coupled bile acid receptor TGR5. | ||
| M5340 | Tauroursodeoxycholate Sodium | ERK |
| TUDCA; Sodium tauroursodeoxycholate; Tauroursodeoxycholic acid sodium salt | ||
| Sodium Tauroursodeoxycholate (TUDC) is a water soluble bile salt, used for the treatment of gallstones and liver cirrhosis. | ||
| M5990 | Taurocholic Acid sodium hydrate | Metabolite/Endogenous Metabolite |
| Sodium taurocholate hydrate; N-Choloyltaurine sodium salt hydrate | ||
| Taurocholic acid sodium hydrate is a deliquescent yellowish crystalline bile acid involved in the emulsification of fats. | ||
| M11507 | Taurolithocholic acid sodium salt | Calcium Channel |
| TLCA | ||
| Taurolithocholic acid sodium salt is an effective bile suppressor and Ca2+ agonist. | ||
| M13346 | Taurodeoxycholate sodium salt | Metabolite/Endogenous Metabolite |
| Sodium Taurodeoxycholate; Taurodeoxycholic acid sodium salt | ||
| Taurodeoxycholate sodium salt is a bile salt formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. It is used as a cholagogue and choleretic, also industrially as a fat emulsifier. | ||
| M13985 | Ursodeoxycholic acid sodium | GPCR19/TGR5 |
| Ursodeoxycholate sodium; Ursodiol sodium; UCDA sodium | ||
| Ursodeoxycholic acid (Ursodeoxycholate) sodium is a secondary bile acid issued from the transformation of (cheno)deoxycholic acid by intestinal bacteria, acting as a key regulator of the intestinal barrier integrity and essential for lipid metabolism. | ||
| M14359 | Cholic acid sodium | Metabolite/Endogenous Metabolite |
| Cholic acid sodium is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. | ||
| M18437 | Taurocholic acid sodium | Animal Modeling |
| Sodium taurocholate; N-Choloyltaurine sodium | ||
| Taurocholic acid sodium (Sodium taurocholate) is a bile salt that can be used to construct models of acute pancreatitis in rats. Taurocholic acid sodium has immunoregulation effect. | ||
| M27695 | Hyodeoxycholic acid sodium | Others |
| HDCA sodium | ||
| Hyodeoxycholic acid sodium salt is a biochemical reagent that can be used as a biological material or organic compound for life science related research. | ||
| M30729 | Glycocholic acid sodium | Metabolite/Endogenous Metabolite |
| Glycocholic acid sodium is an orally active bile acid with anticancer activity, targeting against pump resistance-related and non-pump resistance-related pathways. | ||
| M39714 | Glycolithocholic acid sodium | Others |
| Glycolithocholic acid (Lithocholylglycine) sodium is a glycine-conjugated secondary bile acid. Glycolithocholic acid can be used to diagnose ulcerative colitis (UC), non-alcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC). | ||
| M40604 | Cholic acid sodium hydrate | Metabolite/Endogenous Metabolite |
| Sodium cholate hydrate | ||
| Cholic acid sodium hydrate is the major bile acid produced in the liver, is orally active, and is usually affixed with glycine or taurine to aid in fat absorption and cholesterol excretion. In addition, Cholic acid sodium hydrate is a biosurfactant. | ||
| M42371 | Tauro-α-muricholic acid sodium | Metabolite/Endogenous Metabolite |
| Tauro-α-muricholic acid (T-α-MCA) sodium is a FXR (Farnesoid X receptor) antagonist (IC50=28μM). | ||
| M45007 | Taurochenodeoxycholic acid sodium | Apoptosis |
| Sodium taurochenodeoxycholate | ||
| Taurochenodeoxycholic acid (12-Deoxycholyltaurine) sodium is one of the main bioactive substances of animals' bile acid. | ||
| M55699 | Taurohyodeoxycholic acid sodium | IL Receptor/Related |
| THDCA sodium | ||
| Taurohyodeoxycholic acid (THDCA) sodium prevents apoptosis by blocking a calcium-mediated apoptotic pathway as well as caspase-12 activation. Taurohyodeoxycholic acid sodium can also reduce the activity and expression of myeloperoxidase TNF-α and IL-6, as well as colonic damage in TNBS-induced ulcerative colitis mouse model. | ||
| M55816 | Glycolithocholic acid 3-sulfate disodium | Anti-infection |
| Glycolithocholic acid 3-sulfate (disodium) inhibits replication of HIV-1 in vitro. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
